May 23: Difference between revisions
Jump to navigation
Jump to search
FEisenberg (talk | contribs) No edit summary |
FEisenberg (talk | contribs) No edit summary |
||
| Line 24: | Line 24: | ||
## At risk June 9 | ## At risk June 9 | ||
# White paper | # White paper | ||
## Updated White Paper with content based on discussions of May 19-23 inclusive: [ftp://ftp.ihe.net/Quality/Technical_Comittee/2008/21_5_2008_IHE_QRPH_White_Paper_version1%5B1%5D.doc White paper] | |||
## Requires 2 calls | ## Requires 2 calls | ||
Revision as of 12:12, 23 May 2008
May 23 QRPH Face-to-Face Meeting Minutes
Attendees:
- Floyd Eisenberg (Siemens)
- Jason Colquit (Greenway Medical Systems)
- Sheila Teasdale (AMA)
- Delane Heldt (AMA)
- Harry Solomon (GE)
- Patty Craig (Joint Commission)
- Jan Orton (Intermountain Healthcare)
- Randolph Barrows (MedAllies)
- Daemon Whittenberg (Greenway Medical Systems)
- Joann Larson (Kaiser)
- Ana Estelrich (GMP-DIP)
- Chris Carr (RSNA)
- Clinical Research Profile
- “Other option” requires review – Send to QRPH TC – Schedule one call
- Drug Safety Profile
- Pull content from Clinical Research Profile
- E2B describes data elements
- How to describe what was the adverse event
- Need to identify the information to be send and how based on the trigger
- Calls
- At risk June 9
- White paper
- Updated White Paper with content based on discussions of May 19-23 inclusive: White paper
- Requires 2 calls